13F Data
13F filer · CIK 1858198

KVP Capital Advisors, LP

SAN FRANCISCO, CA · filing since Q4 2025 · last filing Aug 13, 2026
Reported value
$136.2M
+$2.3M vs prior
Positions
35
New / sold out
6 / 3
Added / reduced
2 / 2
Turnover
13.9%
buys $18.7M · sells $38.0M
Top-10 weight
57.4%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewTANDEM DIABETES CARE INC+301,000–+$4.5M
NewARRIVENT BIOPHARMA INC+102,000–+$3.5M
NewDESIGN THERAPEUTICS INC+185,000–+$2.7M
NewMINERALYS THERAPEUTICS INC+84,168–+$2.3M
AddedERASCA INC+115,000+33.8%+$2.1M
NewARTIVA BIOTHERAPEUTICS INC+200,000–+$1.9M
NewEVOLUS INC+150,000–+$1.0M
AddedCOMPASS THERAPEUTICS INC+271,000+54.2%+$593.5K

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outTERNS PHARMACEUTICALS INC-440,000-100.0%$-23.2M
ReducedAXSOME THERAPEUTICS INC.-24,200-66.9%$-5.9M
Sold outREVOLUTION MEDICINES INC-40,200-100.0%$-3.9M
ReducedTRAVERE THERAPEUTICS INC-52,000-57.1%$-3.0M
Sold outSOLENO THERAPEUTICS INC-59,700-100.0%$-2.0M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2025: $103.3MQ1 2026: $133.9MQ2 2026: $136.2M
Q4 2025Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1PRAXIS PRECISION MEDICINES ICOM NEW42,900$14.4M10.54%
2WHITEHAWK THERAPEUTICS INCCOM2,165,997$9.9M7.28%
3ERASCA INCCOM455,000$8.3M6.12%
4TREVI THERAPEUTICS INCCOM414,000$7.7M5.67%
5SUTRO BIOPHARMA INCCOM SHS226,575$7.5M5.52%
6TANGO THERAPEUTICS INCCOM230,264$7.2M5.28%
7MBX BIOSCIENCES INCCOM121,524$6.7M4.92%
8PROTAGONIST THERAPEUTICS INCCOM53,000$6.5M4.77%
9EDGEWISE THERAPEUTICS INCCOM133,000$5.4M3.97%
10TANDEM DIABETES CARE INCCOM NEW301,000$4.5M3.33%
25 more rows. Subscribe for $29/month to see every row, download the data and use the API.